IJGC conversations

In this IJGC podcast, Dr. Pedro Ramirez discusses SENTIX Trial with David Cibula.

Dr. David Cibula graduated from the First Faculty of Medicine at Charles University in Prague in 1992. Since 2003, he has served as the Chair of the Gynecological Oncology Center at the University Hospital in Prague, and in 2022, he became the head of the Department of Gynecology, Obstetrics, and Neonatology.

He is a former President of the Europe...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Frédéric Amant to discuss ESGO/INCIP 2025 Guidelines for Cancer in Pregnancy.

 

Frédéric Amant (MD, PhD) received his medical degree from the University of Leuven (KU Leuven), Belgium in 1992, completed his specialty training as an obstetrician/gynecologist in 1998 and his subspecialty training in gynecologic oncology in 2000. He defended h...

In this IJGC podcast, Dr. Pedro Ramirez discusses SUROVA Study: Surgery vs Neoadjuvant Therapy in Ovarian Cancer with Luis Chiva.

 

Prof. Luis M. Chiva, MD, PhD, is Chair of Obstetrics and Gynecology and Professor of Gynecology and Medical Ethics at the University of Navarra in Pamplona, Spain. An internationally recognized leader in gynecologic oncology, he is renowned for his expertise in complex pelvic oncologic surgery and his ...

In this IJGC podcast, Dr. Pedro Ramirez discusses Updates in Radiotherapy in Gynecologic Cancers with Junzo Chino.

 

Dr. Chino is an Associate Professor of Radiation Oncology and Director of Brachytherapy at the Duke Cancer Center. He has authored over 100 publications in the peer reviewed literature, and his research interests are concentrated in radiation therapy for gynecologic cancer, as well as health services and disparities....

In this IJGC podcast, Dr. Pedro Ramirez discusses Results of the MoST-CIRCUIT Trial with Oliver Klein.

 

A/Prof Klein is a clinician-scientist at the Austin Hospital and the ONJCRI with a 20-year experience in the field of cancer immunotherapy and a particular interest in the treatment of rare gynaecological malignancies. Dr Klein pioneered clinical trials using checkpoint blockade in patients with advanced rare cancers including g...

In this IJGC podcast, Dr. Pedro Ramirez discusses Addition of Metronidazole to Prevent SSI with Megan Gorman and Marina Frimer.

 

Dr. Marina Frimer is a gynecologic oncologist and physician-scientist whose work bridges clinical innovation and translational research in gynecologic malignancies. As Associate Professor at the Zucker School of Medicine at Hofstra/Northwell and Associate Chief for Research and Academic Development at No...

In this IJGC podcast, Dr. Pedro Ramirez discusses Checkpoint Inhibitor Rechallenge in Endometrial Cancer with Brian Slomovitz.

Dr. Slomovitz is a Gynecologic Oncologist at Mount Sinai Medical Center in Miami Beach, Florida, and Professor of Obstetrics and Gynecology at the Wertheim College of Medicine at Florida International University. He is an internationally recognized leader in gynecologic oncology clinical trials, specific...

In this IJGC podcast, Dr. Pedro Ramirez discusses PEACOCC Trial: Pembrolizumab in Clear Cell Cancer with Rebecca Kristeleit.

 

Rebecca Kristeleit is a Consultant Medical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust and an Adjunct Associate Professor in the Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences at KCL, London. She is Research Lead for gynaecological cancer, ...

In this IJGC podcast, Dr. Pedro Ramirez discusses ADCs and Oral Mucositis: Strategies for Gynecologic Oncologists with Michelle D. Lightfoot.

 

Michelle D. Lightfoot, MD, joined NYU Langone in August 2021 after completing fellowship training in gynecologic oncology at The Ohio State University. She received her medical degree from Harvard Medical School and a master’s in public health from Columbia University’s Mailman School of Pu...

In this IJGC podcast, Dr. Pedro Ramirez discusses ROSELLA Trial: Relacorilant in Platinum-resistant Ovarian Cancer with Alexander B. Olawaiye.

Dr. Olawaiye a Professor and  Vice Chair for DI at the Department of Obstetrics, Gynecology and Reproductive Sciences. He is director of gynecologic cancer research at Magee-Women’s Hospital of the University of Pittsburgh Medical Center, and has overseen multiple clinical research projects...

In this IJGC podcast, Dr. Pedro Ramirez discusses Carcinosarcoma with no myoinvasion with Giuseppe Cucinella and Mario M. Leitao, Jr.

Giuseppe Cucinella, MD, is a gynecologist working at Istituto Nazionale Tumori IRCSS Fondazione G.Pascale in Naples, Italy (Department of Gynecologic Oncology). During his residency, he worked as a research fellow at Mayo Clinic in Rochester, Minnesota, where he focused on the study of endometrial ca...

In this IJGC podcast, Dr. Pedro Ramirez discusses SENTIX Trial with David Cibula.

Dr. David Cibula graduated from the First Faculty of Medicine at Charles University in Prague in 1992. Since 2003, he has served as the Chair of the Gynecological Oncology Center at the University Hospital in Prague, and in 2022, he became the head of the Department of Gynecology, Obstetrics, and Neonatology.

He is a former President of the European S...

In this IJGC podcast, Dr. Pedro Ramirez discusses RAMP 201 Results: Avutometinib and Defactinib in Low-Grade Serous Ovarian Cancer with Susana N Banerjee and Rachel N. Grisham.

Prof Susana Banerjee MBBS MA PhD FRCP is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit at The Royal Marsden NHS Foundation Trust, London. She is also Professor in Women’s Cancers at the Institute of Cancer Research. Dr Banerjee s...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Tyler Hillman and Allison Lynn Brodsky to discuss Surgical Approach in Recurrent Granulosa Cell Tumor.

 

Tyler Hillman, MD, PhD, is a board-certified gynecologic oncologist at UC San Diego Health, where he specializes in medical and surgical management of gynecologic cancers, with expertise in minimally invasive surgery, symptom management, an...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Bradley Monk to discuss ctDNA: Results from CALLA Trial.

 

Bradley Monk, MD, FACOG, FACS is a board-certified gynecologic oncologist with Florida Cancer Specialists & Research Institute and medical director of the Late-Stage Clinical Research Program. He provides care to patients at the FCS West Palm Beach location. Dr. Monk has extensive l...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Frédéric Amant to discuss ESGO/INCIP 2025 Guidelines for Cancer in Pregnancy.

 

Frédéric Amant (MD, PhD) received his medical degree from the University of Leuven (KU Leuven), Belgium in 1992, completed his specialty training as an obstetrician/gynecologist in 1998 and his subspecialty training in gynecologic oncology in 2000. He defended his t...